SEC Filing | FARO Technologies Inc

View:

Download DOC

Download PDF

Download XLS

Unassociated Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q


x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	For the quarterly period ended October 1, 2005


o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________ to __________

Commission File Number: 0-23081

FARO TECHNOLOGIES, INC.

(Exact name of Registrant as specified in its charter)


Florida	59-3157093
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

125 Technology Park, Lake Mary, Florida	32746
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s Telephone Number, including area code:	(407) 333-9911

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES x NO o

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). YES x NO o

The number of shares outstanding of the registrant’s common stock as of November 2, 2005 was 14,458,623.

FARO TECHNOLOGIES, INC.

Quarterly Report on Form 10-Q

Quarter Ended October 1, 2005

INDEX


PART I. FINANCIAL INFORMATION		Page Number

Item 1.	Financial Statements
a)	Consolidated Balance Sheets (Unaudited)
	As of October 1, 2005 and December 31, 2004	3

b)	Consolidated Statements of Income (Unaudited)
	For the Three Months and Nine Months Ended October 1, 2005 and October 2, 2004	4

c)	Consolidated Statements of Cash Flows (Unaudited)
	For the Nine Months Ended October 1, 2005 and October 2, 2004	5

d)	Notes to Consolidated Financial Statements (Unaudited)
	For the Nine Months Ended October 1, 2005 and October 2, 2004	6-12

Item 2.	Management’s Discussion and Analysis of Financial Condition
	and Results of Operations	13-21

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	21

Item 4.	Controls and Procedures	21

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings	22

Item 4.	Submission of Matters to a Vote of Security Holders	22

Item 5.	Other Information	22

Item 6.	Exhibits	22

SIGNATURES		23

CERTIFICATIONS		24-27

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

FARO TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(UNAUDITED)


	October 1,			December 31,
(in thousands, except share data)	2005			2004
ASSETS
Current Assets:
Cash and cash equivalents	$	10,959		$	16,357
Short-term investments		10,990			22,485
Accounts receivable, net		28,424			22,484
Inventories		26,069			16,378
Deferred income taxes, net		2,772			744
Prepaid expenses and other current assets		2,943			2,538
Total current assets		82,157			80,986
Property and Equipment:
Machinery and equipment		6,630			4,352
Furniture and fixtures		2,881			2,394
Leasehold improvements		1,635			910
Property and equipment at cost		11,146			7,656
Less: accumulated depreciation and amortization		(5,297	)		(3,641	)
Property and equipment, net		5,849			4,015
Goodwill		14,030			8,077
Intangible assets, net		6,900			3,568
Service Inventory		3,826			4,159
Deferred income taxes, net		3,286			4,273
Total Assets	$	116,048		$	105,078
LIABILITIES AND SHAREHOLDERS' EQUITY
Current Liabilities:
Accounts payable	$	6,355		$	4,736
Accrued liabilities		6,416			7,252
Income taxes payable		995			104
Current portion of unearned service revenues		2,230			2,663
Customer deposits		306			441
Current portion of long-term debt and obligations under capital leases		104			104
Total current liabilities		16,406			15,300
Unearned service revenues - less current portion		1,557			474
Long-term debt and obligations under capital leases - less current portion		254			146
Total Liabilities		18,217			15,920
Commitments and contingencies - See Note O
Shareholders' Equity:
Common stock - par value $.001, 50,000,000 shares authorized; 14,455,222 and 14,004,092 issued; 14,252,778 and 13,964,092 outstanding, respectively		14			14
Additional paid-in-capital		82,641			78,282
Deferred compensation		221			505
Retained earnings		17,073			9,077
Accumulated other comprehensive (loss) income		(1,967	)		1,431
Common stock in treasury, at cost - 40,000 shares		(151	)		(151	)
Total shareholders' equity		97,831			89,158
Total Liabilities and Shareholders' Equity	$	116,048		$	105,078

The accompanying notes are an integral part of these consolidated financial statements.

FARO TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(UNAUDITED)


	Three Months Ended						Nine Months Ended
(in thousands, except per share data)	Oct 1, 2005			Oct 2, 2004			Oct 1, 2005			Oct 2, 2004

SALES	$	32,598		$	23,376		$	91,109		$	68,478
COST OF SALES (exclusive of depreciation and amortization, shown separately below)		14,913			8,619			37,691			25,029
Gross profit		17,685			14,757			53,418			43,449

OPERATING EXPENSES:
Selling		8,631			5,803			25,654			17,600
General and administrative		3,169			3,217			11,005			8,416
Depreciation and amortization		967			567			2,447			1,661
Research and development		1,864			1,336			4,824			3,984
Total operating expenses		14,631			10,923			43,930			31,661
INCOME FROM OPERATIONS		3,054			3,834			9,488			11,788

OTHER INCOME (EXPENSE)
Interest income		116			86			419			234
Other (expense) income, net		(191	)		(164	)		(330	)		215
Interest expense		(4	)		(1	)		(83	)		(6	)
INCOME BEFORE INCOME TAX		2,975			3,755			9,494			12,231

INCOME TAX EXPENSE		360			690			1,498			2,215
NET INCOME	$	2,615		$	3,065		$	7,996		$	10,016

NET INCOME PER SHARE - BASIC	$	0.18		$	0.22		$	0.56		$	0.73

NET INCOME PER SHARE - DILUTED	$	0.18		$	0.22		$	0.56		$	0.72

The accompanying notes are an integral part of these consolidated financial statements.

FARO TECHNOLOGIES, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)



	Nine Months Ended
	Oct 1,			Oct 2,
(in thousands)	2005			2004
CASH FLOWS FROM:
OPERATING ACTIVITIES:
Net income	$	7,996		$	10,016
Adjustments to reconcile net income to net cash (used in)
provided by operating activities:
Depreciation and amortization		2,447			1,661
Income tax benefit from exercise of stock options		407			2,237
Deferred income taxes		(1,041	)		(588	)
Employee stock option (income) expense		(175	)		47
Change in operating assets and liabilities:
Decrease (increase) in:
Accounts receivable, net		(7,409	)		(1,672	)
Inventories		(10,169	)		(6,865	)
Prepaid expenses and other current assets		(302	)		(875	)
Increase (decrease) in:
Accounts payable and accrued liabilities		(772	)		(215	)
Income taxes payable		924			(794	)
Customer deposits		(187	)		(219	)
Unearned service revenues		833			625

Net cash (used in) provided by operating activities		(7,448	)		3,358

INVESTING ACTIVITIES:
Acquisition of iQvolution		(6,385	)		—
Purchases of property and equipment		(2,936	)		(1,969	)
Payments for intangible assets		(174	)		(584	)
Purchases of short-term investments		(3,300	)		(28,418	)
Proceeds from short-term investments		14,795			21,370

Net cash provided by (used in) investing activities		2,000			(9,601	)

FINANCING ACTIVITIES:
Payments on line of credit and capital leases		(26	)		24
Proceeds from issuance of stock, net		344			1,122
Net cash provided by financing activities		318			1,146

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS		(268	)		(154	)

DECREASE IN CASH AND CASH EQUIVALENTS		(5,398	)		(5,251	)

CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD		16,357			17,425

CASH AND CASH EQUIVALENTS, END OF PERIOD	$	10,959		$	12,174

The accompanying notes are an integral part of these consolidated financial statements.

FARO TECHNOLOGIES, INC. AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

For the Nine Months Ended October 1, 2005 and October 2, 2004

(Unaudited)

(in thousands, except share and per share data, or as otherwise noted)

NOTE A - DESCRIPTION OF BUSINESS

FARO Technologies, Inc. and subsidiaries (collectively the “Company” or “FARO”) develop, manufacture, market and support software-based three-dimensional measurement devices for manufacturing, industrial, building construction and forensic applications. The Company’s principal products include the Faro Arm, Faro Scan Arm, Digital Template and Faro Gage, all articulated electromechanical measuring devices, and the Faro Laser Tracker and the Faro Laser Scanner LS, both laser-based measuring devices. Markets for the Company’s products include automobile, aerospace, heavy equipment, countertop manufacturers and law enforcement agencies. The Company sells the vast majority of its products though a direct sales force located in many of the world’s largest industrialized countries.

NOTE B - PRINCIPLES OF CONSOLIDATION

The consolidated financial statements of the Company include the accounts of FARO Technologies, Inc. and all its subsidiaries. All intercompany transactions and balances have been eliminated. The financial statements of the Company’s foreign subsidiaries are translated into U.S. dollars using exchange rates in effect at period-end for assets and liabilities and average exchange rates during each reporting period for results of operations. Adjustments resulting from financial statement translations are reflected as a separate component of accumulated other comprehensive income.

NOTE C - BASIS OF PRESENTATION

The consolidated financial statements of the Company include all adjustments, consisting of only normal recurring items, considered necessary by management for their fair presentation in conformity with accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The consolidated results of operations for the nine months ended October 1, 2005 are not necessarily indicative of results that may be expected for the year ending December 31, 2005 or any future period.

The information included in this Form 10-Q, including the interim consolidated financial statements and notes that accompany these financial statements, should be read in conjunction with the audited consolidated financial statements and related notes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2004.

NOTE D - RECLASSIFICATIONS

Certain amounts have been reclassified to conform to the current period presentation.

NOTE E - IMPACT OF RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS

In December 2004, the Financial Accounting Standards Board (“FASB”) issued SFAS No. 123R, “Share-Based Payment.” SFAS No. 123R requires employee stock options and rights to purchase shares under stock participation plans to be accounted for under the fair value method, and eliminates the ability to account for these instruments under the intrinsic value method prescribed by APB Opinion No. 25, as allowed under the original provisions of SFAS No. 123. SFAS No. 123R requires the use of an option pricing model for estimating fair value, which is amortized to expense over the service periods. SFAS No. 123R allows for two alternative transition methods. The first method is the modified prospective application whereby compensation cost for the portion of awards for which the requisite service has not yet been rendered that are outstanding as of the adoption date will be recognized over the remaining service period. The compensation cost for that portion of awards will be based on the grant date fair value of those awards as calculated for pro forma disclosures under SFAS No. 123, as originally issued. All new awards and awards that are modified, repurchased, or cancelled after the adoption date will be accounted for under the provisions of SFAS No. 123R. The second method is the modified retrospective application, which requires that the Company restates prior period financial statements. The modified retrospective application may be applied either to all periods or only to prior interim periods in the year of adoption of this statement. The requirements of SFAS No. 123R were effective for interim or fiscal periods beginning after June 15, 2005. The SEC has delayed the required implementation date of this rule to the beginning of the next fiscal year, instead of the next reporting period that begins after June 15, 2005. The Company intends to adopt the provisions of SFAS No. 123R effective January 1, 2006, but is currently determining which transition method it will adopt and is evaluating the impact SFAS No. 123R will have on its financial position, results of operations and cash flows when SFAS No. 123R is adopted, including potentially accelerating the vesting of options prior to December 31, 2005.

NOTE F - STOCK-BASED COMPENSATION

In December 2002, the FASB issued SFAS No. 148, “Accounting for Stock-Based Compensation-Transition and Disclosure.” SFAS No. 148 provides alternative methods of transition for a voluntary change to the fair value based method of accounting for stock-based compensation. In addition, SFAS No. 148 amends the disclosure requirements of SFAS No. 123, “Accounting for Stock-Based Compensation,” to require prominent disclosures in both annual and interim financial statements about the method of accounting for stock-based compensation and the effect of the method used on reported results. SFAS No. 148 is effective for financial statements for fiscal years ending after December 15, 2002 and for interim periods beginning after December 15, 2002. The annual disclosure requirements of SFAS No. 148 were adopted by the Company on January 1, 2003.

In accordance with SFAS No. 123, the Company has elected to continue to account for its employee stock compensation plans using the intrinsic value based method with pro-forma disclosures of net earnings and earnings per share, as if the fair value based method of accounting defined in SFAS No. 123 had been applied. Under the intrinsic value based method, compensation cost is measured by the excess, if any, of the quoted market price of the stock at the grant date over the amount an employee must pay to acquire the stock. Under the fair value based method, compensation cost is measured at the grant date based on the fair value of the award and is recognized over the service period, which is usually the vesting period. Included in net income are certain compensation expenses subject to variable accounting treatment.

Had compensation cost for the Company’s stock-based compensation plans been determined consistent with the fair value based method under SFAS No. 123, the Company’s net income and earnings per share would have been as follows:


	Three Months Ended						Nine Months Ended
	Oct 1, 2005			Oct 2, 2004			Oct 1, 2005			Oct 2, 2004
Net income, as reported	$	2,615		$	3,065		$	7,996		$	10,016

Add (Deduct): Stock-based employee compensation expense (income) included in reported net income, net of related tax effects		(72	)		(1	)		(109	)		30

Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects		(667	)		(461	)		(1,894	)		(757	)
Pro forma net income	$	1,876		$	2,603		$	5,993		$	9,289

Earnings per share:
Basic - as reported	$	0.18		$	0.22		$	0.56		$	0.73
Basic - pro forma	$	0.13		$	0.19		$	0.42		$	0.68
Diluted - as reported	$	0.18		$	0.22		$	0.56		$	0.72
Diluted - pro forma	$	0.13		$	0.19		$	0.42		$	0.67

NOTE G - SUPPLEMENTAL CASH FLOW INFORMATION

Selected cash payments and non-cash activity were as follows:


	Nine Months Ended
	Oct 1, 2005		Oct 2, 2004
Cash paid for interest	$	82	$	6
Cash paid for income taxes		982		—
Cash received from income tax refund		1,161		—

Non-Cash Activity:
Value of shares issued for acquisition of iQvolution	$	3,504	$	—
Retirement of fully depreciated property and equipment		—		4,016

NOTE H - ACCOUNTS RECEIVABLE

Accounts receivable consist of the following:


	As of			As of
	Oct 1, 2005			Dec. 31, 2004
Accounts receivable	$	28,685		$	22,823
Allowance for doubtful accounts		(261	)		(339	)
Total	$	28,424		$	22,484

NOTE I - INVENTORIES

Commencing January of 2005, the Company implemented a new enterprise resource planning (“ERP”) system. In order to ensure that the system had been properly implemented, management tested the physical inventory in October of 2005. This testing identified a difference between the book balance reflected in the financial records and the physical inventory of approximately $1.6 million related to inventory costing and consumption variances. The Company believes that this represented a significant deficiency with regard to the Company’s internal controls. As a result of the discovery of this significant deficiency, the Company reviewed the inventory and production process maps and controls and implemented changes to its internal control over financial reporting. These changes include, but are not limited to, the security for item card setup and change, cycle count sample sizes and controls over the physical inventory reconciliation process. The implementation of the remediation steps has been completed and the Company has already performed some tests and will continue to test the effectiveness of these remediation steps during the remainder of 2005.

Inventories consist of the following:


	As of			As of
	Oct 1, 2005			Dec. 31, 2004
Raw materials	$	11,283		$	6,620
Work-in-process		137			428
Finished goods		4,400			1,424
Sales Demonstration Inventory		10,633			8,097
Reserve for Obsolescence		(384	)		(191	)
Inventory		26,069			16,378
Service Inventory		3,826			4,159
Total	$	29,895		$	20,537

NOTE J - EARNINGS PER SHARE

A reconciliation of the number of common shares used in the calculation of basic and diluted earnings per share (EPS) is presented below:


	Three Months Ended								Nine Months Ended
	October 1, 2005				October 2, 2004				October 1, 2005				October 2, 2004
	Shares		Per-Share Amount		Shares		Per-Share Amount		Shares		Per-Share Amount		Shares		Per-Share Amount

Basic EPS		14,247,089	$	0.18		13,932,463	$	0.22		14,169,733	$	0.56		13,677,119	$	0.73
Effect of dilutive securities		182,862	$	—		132,304	$	—		194,195	$	—		154,879	$	(0.01	)
Diluted EPS		14,429,951	$	0.18		14,064,767	$	0.22		14,363,928	$	0.56		13,831,998	$	0.72

NOTE K - ACCRUED LIABILITIES

Accrued liabilities consist of the following:


	As of		As of
	Oct 1, 2005		Dec. 31, 2004
Accrued compensation and benefits	$	2,334	$	3,046
Accrued warranties		848		565
Professional and legal fees		954		930
Other accrued liabilities		2,280		2,711
	$	6,416	$	7,252

NOTE L - INCOME TAX EXPENSE

The tax provision for the nine months ended October 1, 2005 differs from the tax provision for the nine months ended October 2, 2004, principally due to a decrease in earnings. The effective tax rate for the nine months ended October 1, 2005 was 15.8% which continues to be lower than the statutory tax rate in the United States resulting primarily from favorable tax rates and the use of previously reserved net operating loss carryforwards in foreign jurisdictions. For the nine months ended October 1, 2005, approximately $0.9 million was added to deferred income taxes as a result of the generation of net operating loss carryforwards. Of this amount, the Company has recorded a valuation allowance of $0.9 million, as it is more likely than not that these amounts will not be realized based on current estimates of future income. For the nine months ended October 1, 2005, the Company utilized $0.5 million of net operating loss carryforwards as a result of income in certain jurisdictions, for which a valuation allowance had been previously applied. Total deferred income taxes for the Company’s foreign subsidiaries relating to net operating loss carryforwards were $3.9 million and $3.4 million at October 1, 2005 and December 31, 2004, respectively. The related valuation allowance was $2.1 million and $1.6 million at October 1, 2005 and December 31, 2004, respectively.

NOTE M - GEOGRAPHIC DATA

The Company develops, manufactures, markets and supports software-based three dimensional measurement devices for inspection, reverse engineering and for gathering crime scene data. This one line of business represents approximately 99% of consolidated sales and is the Company’s only segment. The Company operates through sales teams established by geographic area. Each team is equipped to deliver the entire line of Company products to customers within its geographic area.

The following table presents information about the Company by geographic area:


	Three Months Ended				Nine Months Ended
	Oct 1, 2005		Oct 2, 2004		Oct 1, 2005		Oct 2, 2004
SALES
Americas Region	$	13,479	$	9,905	$	39,422	$	28,728
Europe/Africa Region		10,469		9,928		34,408		30,818
Asia Pacific Region		8,650		3,543		17,279		8,932
TOTAL	$	32,598	$	23,376	$	91,109	$	68,478

NOTE N - OTHER COMPREHENSIVE INCOME

Other comprehensive income includes the effect of currency translation adjustments on the investments in (capitalization of) foreign subsidiaries combined with their accumulated earnings.

	Three Months Ended				Nine Months Ended
	Oct 1, 2005		Oct 2, 2004		Oct 1, 2005			Oct 2, 2004
NET INCOME	$	2,615	$	3,065		7,996			10,016
OTHER COMPREHENSIVE INCOME (LOSS):
Currency translation adjustments		754		205		(3,398	)		(397	)
COMPREHENSIVE INCOME	$	3,369	$	3,270	$	4,598		$	9,619

NOTE O - COMMITMENTS AND CONTINGENCIES

Leases—The Company is party to leases arising in the normal course of business, including leases with related parties, that expire on or before 2009. Total obligations under these leases will be approximately $1.7 million for 2005.

Purchase Commitments—The Company enters into purchase commitments for products and services in the ordinary course of business. These purchases generally cover production requirements for 60 to 90 days. On August 11, 2005, FARO entered into an agreement with DELCAM plc under which the Company agreed to purchase approximately $1.4 million in products over a 12-month term. Other than this agreement, the Company does not have any long-term commitments for purchases.

Litigation—On November 25, 2003, Cimcore-Romer filed a patent infringement suit against FARO in the Federal District Court for the Southern District of California alleging that certain of the Company’s products sold in the United States, including the FARO Arm, infringe U.S. Patent 5,829,148 ('148 patent). On July 12, 2005, the court issued an order granting Cimcore-Romer's motion for summary judgment of infringement of three claims of the ‘148 patent. In that lawsuit, the Company claimed that it does not infringe the '148 patent and that the '148 patent is invalid. The District Court has not yet ruled on the Company’s allegation that the '148 patent is invalid.

On July 22, 2005, the Company announced its decision to limit the capability of its U.S.-based FARO Arm products (the FARO Arm, the FARO Gage and the Digital Template) by removing what the Company calls the "infinite rotation feature" by reducing this capability to 50 rotations or fewer. FARO believes that by limiting the range of the joint rotation to 50 rotations, it has removed from its U.S. products the ability to sweep through an unlimited arc, which is a feature of the ‘148 patent claims addressed by the court’s ruling required to infringe the '148 patent. The revised products have not, however, been considered by the courts. Accordingly, the Company cannot provide assurance that the revised products will not be deemed to infringe the ‘148 patent.

On September 20, 2005, the Judge presiding over the case withdrew his order of summary infringement and agreed to reconsider his conclusions from the Markman, which is a pretrial hearing often used in patent infringement cases. The new Markman hearing occurred on October 3, 2005 and the hearing-on-summary judgments of infringement is scheduled for November 14, 2005. In addition, the U.S. Patent and Trademark Office has determined that a substantial new question of patentability exists and has granted FARO’s request that the '148 patent be reexamined. After investigating and analyzing the Cimcore-Romer infringement claims, the Company believes that they are without merit, and plans to continue to defend against them vigorously. In the event of an adverse ruling in the Cimcore-Romer litigation, however, FARO could be required to pay substantial damages, cease the manufacturing, use and sale of any infringing products, discontinue the use of certain processes or obtain a license, if available, from Cimcore-Romer with royalty payment obligations by the Company. An adverse decision in the Cimcore-Romer case could materially and adversely affect FARO’s financial condition and results of operations. At this time, however, the Company cannot estimate the potential impact, if any, that might result from this suit, and therefore, no provision has been made to cover such expense. The Company has spent approximately $0.8 million in legal fees in the first nine months of 2005 in connection with this case.

Other than the litigation mentioned above, the Company is not involved in any other legal proceedings other than routine litigation arising in the normal course of business. The Company does not believe the results of such litigation, even if the outcome were unfavorable to the Company, would have a material adverse effect on the Company’s business, financial condition or results of operations.

NOTE P - CREDIT FACILITY

The Company has an available line of credit of $5 million. Terms of this line of credit require the Company to maintain certain ratios and balances with respect to a debt covenant agreement, including current ratio, consolidated EBITDA, indebtedness to consolidated net worth, fixed charge coverage ratio and consolidated tangible net worth. As of October 1, 2005 and December 31, 2004, the Company was in compliance with the required ratios. Drawings under the line of credit bear interest at a rate equivalent to LIBOR plus 1.75%. The line of credit is due on demand. There were no amounts outstanding under the line of credit at October 1, 2005 or October 2, 2004.

NOTE Q - ACQUISITION

On March 29, 2005, the Company acquired 100% of the outstanding stock of privately held iQvolution AG ("iQvolution"). iQvolution, headquartered in Ludwigsburg, Germany, manufactures and supplies three-dimensional laser scanning products and services. This purchase was a strategic acquisition to enable the Company to enter broader three-dimensional measurement markets. The purchase price for the transaction was approximately $13.6 million, including an initial cash payment of approximately $4.3 million and 314,736 shares of common stock valued at approximately $7.2 million based on the average closing price for the three days immediately preceding the closing, 152,292 shares of which were payable immediately. The remaining 162,444 shares of common stock, valued at approximately $3.7 million, are being held in escrow and may be paid over the following five years subject to achieving predetermined milestones with respect to purchased assets. There were no predetermined milestone dates that expired in the third quarter that would trigger payment of additional consideration. Subsequent to the purchase, approximately $1.8 million in cash was paid out for the repayment of loans and approximately $0.4 million was paid in fees associated with the purchase. Additionally, the purchase price was adjusted downward by $0.1 million, and these funds were repaid to the Company in the third quarter relating to the settlement of a purchase price adjustment clause within the purchase agreement. During the third quarter, approximately $3.8 million of the purchase price was allocated to intangible assets reflecting the company's estimate of the fair value of technology and software assets acquired. The current purchase price and the allocation between goodwill and intangible assets is subject to adjustment in subsequent quarters based on the completion of post-acquisition due diligence.

The operating results of iQvolution have been included in the consolidated statements of income since the date of acquisition. The following unaudited pro-forma results of operations for the three and nine months ended October 1, 2005 and October 2, 2004 are presented for informational purposes only and do not purport to be indicative of the results of operations which actually would have resulted had the acquisition occurred on the date indicated, or the results of operations which may result in the future.


		Three Months Ended				Nine Months Ended
(unaudited)		Oct 1, 2005		Oct 2, 2004		Oct 1, 2005		Oct 2, 2004
Revenues	$	32,598	$	24,845	$	91,480	$	72,928
Net income	$	2,615	$	2,811	$	7,280	$	9,245
Income per share:
Basic	$	0.18	$	0.20	$	0.51	$	0.67
Diluted	$	0.18	$	0.20	$	0.51	$	0.66

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following information should be read in conjunction with the Consolidated Financial Statements, including the notes thereto, included elsewhere in this Form 10-Q, and the Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s 2004 Annual Report, Form 10-K, for the year ended December 31, 2004.

FARO Technologies, Inc. (“FARO”, the “Company”, ”us”, “we”, or “our”) has made "forward-looking statements" in this report (within the meaning of the Private Securities Litigation Reform Act of 1995). Statements that are not historical facts or that describe our plans, beliefs, goals, intentions, objectives, projections, expectations, assumptions, strategies, or future events are forward-looking statements. In addition, words such as "may," "will," "believe," "plan," "should," "could," "seek," "expect," "anticipate," "intend," "estimate," "goal," "objective," "project," "forecast," "target" and similar words, or discussions of our strategy or other intentions identify forward-looking statements. Other written or oral statements that constitute forward-looking statements also may be made by the Company from time to time.

Forward-looking statements are not guarantees of future performance and are subject to a number of known and unknown risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. Consequently, undue reliance should not be placed on these forward-looking statements. We do not intend to update any forward-looking statements, whether as a result of new information, future events, or otherwise, unless otherwise required by law. Important factors that could cause a material difference in the actual results from those contemplated in such forward-looking statements include among others those under "Cautionary Statements" and elsewhere in this report and the following:

·	our inability to further penetrate our customer base;

·	development by others of new or improved products, processes or technologies that make our products obsolete or less competitive;

·	our inability to maintain our technological advantage by developing new products and enhancing our existing products;

·	our inability to successfully identify and acquire target companies or achieve expected benefits from acquisitions that are consummated, including our inability to effectively integrate the iQvolution acquisition and achieve the expected benefits from it;

·	the cyclical nature of the industries of our customers and the financial condition of our customers;

·	the fact that the market potential for the CAM2 market and the potential adoption rate for our products are difficult to quantify and predict;

·	the inability to protect our patents and other proprietary rights in the United States and foreign countries and the assertion and ultimate outcome of infringement claims against us, including the pending suit by Cimcore-Romer against us;

fluctuations in our annual and quarterly operating results as a result of a number of factors including, but not limited to litigation brought against us, quality issues with our products, excess or obsolete inventory, raw material price fluctuations, expansion of our manufacturing capability and other inflationary pressures;

·	the inability of our products to displace traditional measurement devices and attain broad market acceptance;

·	the impact of competitive products and pricing in the CAM2 market and the broader market for measurement and inspection devices;

·	the effects of increased competition as a result of recent consolidation in the CAM2 market;

·	risks associated with expanding international operations, such as fluctuations in currency exchange rates, difficulties in staffing and managing foreign operations, political and economic instability, and the burdens of complying with a wide variety of foreign laws and labor practices;

·	our inability to continue to grow sales in the Asia Pacific region;

our inability to keep our financial results within our target goals as a result of various potential factors such as investments in potential acquisitions or strategic sales, product or other initiatives, shrinkage or other inventory losses due to product obsolescence, scrap or material price changes;

·	our inability to find less expensive alternatives to stock options to attract and retain employees;

·	the loss of our Chief Executive Officer, our President and Chief Operating Officer, our Executive Vice President, Secretary and Treasurer, or our Chief Financial Officer or other key personnel;

·	the failure to effectively manage our growth;

·	difficulty in predicting our effective tax rate; and

·	the loss of a key supplier and the inability to find a sufficient alternative supplier in a reasonable period or on commercially reasonable terms.

Overview

The Company designs, develops, markets and supports portable, software driven, 3-D measurement systems that are used in a broad range of manufacturing, industrial, building construction and forensic applications. The Company's Faro Arm, Faro Scan Arm and Faro Gage articulated measuring devices, the Faro Laser Tracker, and their companion CAM2 software, provide for Computer-Aided Design (CAD)-based inspection and/or factory-level statistical process control. Together, these products integrate the measurement, quality inspection, and reverse engineering functions with CAD software to improve productivity, enhance product quality and decrease rework and scrap in the manufacturing process. The Company uses the acronym “CAM2” for this process, which stands for computer-aided manufacturing measurement. The Company’s Digital Template articulated measuring device and its related software are used to measure the shape of existing counter tops and other structures in residential or commercial buildings to provide the data required to manufacture replacement countertops or other structures. The Digital Template reduces the time required to measure these existing products and to provide the data to manufacturing machines to create the replacement structures, compared to traditional techniques. In March 2005 the Company acquired iQvolution AG, a German designer, developer and manufacturer of a portable laser-based device for measuring the detailed composition of factories, oil refineries and other structures. This device and its related software, which the Company will sell under the product name Laser Scanner LS also has forensic applications such as capturing detailed 3D crime scene information. The Company continues to hire new sales people with building construction and law enforcement experience for these market segments. The Company's products have been purchased by approximately 3,800 customers worldwide, ranging from small machine shops to such large manufacturing and industrial companies as Audi, Bell Helicopter, Boeing, British Aerospace, Caterpillar, Daimler Chrysler, General Electric, General Motors, Honda, Johnson Controls, Komatsu Dresser, Lockheed Martin, Nissan, Siemens and Volkswagen, among many others.

We continue to expand in international markets. We established sales offices in France and Germany in 1996, Great Britain in 1997, Japan and Spain in 2000, Italy in 2001, and China in 2003. We opened sales offices in South Korea and India in the fourth quarter of 2004. In 2003 we began to manage and report our global sales in three regions: the Americas, Europe/Africa and Asia/Pacific. In the first nine months of 2005 43.2% of our sales were in the Americas compared to 42.0% in the first nine months of 2004, 37.8% were in the Europe/Africa region compared to 45.0% in the first nine months of 2004 and 19.0% were in the Asia/Pacific region, compared to 13.0% in the first nine months of 2004 (see also Note M Geographic Data to the financial statements above). Although we expect variations in the percentage of our sales in the Asia/Pacific region from quarter to quarter going forward, we generally expect higher percentage sales growth in the Asia/Pacific region than the other regions in the remainder of 2005 and in 2006 as a result of our new sales offices in China, India and South Korea, and the addition of sales personnel and the opening of a service center in our Japan office. We opened an Asia/Pacific regional headquarters in Singapore in the third quarter of 2005 and we expect to open a manufacturing plant there in the fourth quarter of 2005.

We derive revenues primarily from the sale of our Faro Arm, Faro Scan Arm, Faro Gage, Digital Template, Faro Laser Scanner LS and Faro Laser Tracker 3-D measurement equipment, and their related software. Revenue related to these products is recognized upon shipment. In addition, we sell one and three-year extended warranties and training and technology consulting services relating to our products. We recognize the revenue from extended warranties on a straight-line basis. We also receive royalties from licensing agreements for our historical medical technology and generally recognize the revenue from these royalties as licensees use the technology. Royalties from licensing agreements were $542,000 and $656,000 in the first nine months of 2005 and 2004, respectively.

In 2003, we began to manufacture our Faro Arm products in Switzerland for customer orders from the Europe/Africa and Asia/Pacific regions. We began to manufacture our Faro Gage product, and parts of our Faro Laser Tracker product in our Swiss plant in the third quarter of 2004and our Faro Laser Tracker product in the second quarter of 2005. The production of these products for customer orders from the Americas will be done in our manufacturing facilities located in Florida and Pennsylvania. In March 2005 we acquired iQvolution AG (“iQvolution”), who manufactured the predecessor to the Faro Laser Scanner LS, and we completed the move of the manufacturing of iQvolution’s products to our Swiss factory in the third quarter of 2005. We expect all our existing plants to have the production capacity necessary to support our growth, at least through 2006.

In our previously filed Form 10-K for 2004 we said that we expected to recognize expenses of approximately $2 million in 2005 as calculated under the Black-Scholes method of SFAS No. 123, related to our expected adoption of SFAS No. 123(R) for the expensing of stock options. We will not recognize these expenses in 2005 because the SEC has delayed the required implementation date of this rule to the beginning of the next fiscal year, instead of the next reporting period that begins after June 15, 2005. This allows the Company to defer the effect of SFAS No. 123(R) until the first quarter of 2006.

Our effective tax rate in the first nine months of 2005 was 15.8%, slightly lower than the first nine months of 2004, which continues to be lower than the statutory tax rate in the United States resulting primarily from favorable tax rates in foreign jurisdictions. We expect the blended (consolidated) tax rate to be between 15% and 17% for 2005, and this could fluctuate depending upon, among other things, our ability to use more previously reserved net operating loss carry-forwards and the proportion of income in foreign jurisdictions. See “Critical Accounting Policies - Income Taxes” below. In the full year 2003 and 2004 we have been able to use previously reserved net operating loss carry-forwards, which reduced our effective tax rate to 12.3% in 2003 and 2.3% in 2004.

Accounting for wholly-owned foreign subsidiaries is maintained in the currency of the respective foreign jurisdiction and, therefore, fluctuations in exchange rates may have an impact on inter-company accounts reflected in our consolidated financial statements. We are aware of the availability of off-balance sheet financial instruments to hedge exposure to foreign currency exchange rates, including cross-currency swaps, forward contracts and foreign currency options (see Foreign Exchange Exposure below). However, we do not regularly use such instruments, and none were utilized during 2005.

We have had thirteen consecutive profitable quarters through October 1, 2005. This followed a period of losses in 2001 and the first half of 2002, which resulted from an economic slowdown in manufacturing in 2001, and expenses arising from the acquisition in January 2002 of SpatialMetriX Corporation (SMX). Our sales growth and return to profitability since then was a result of a number of factors including the acquisition of SMX, which manufactured the predecessor to the Faro Laser Tracker, the introduction in October 2002 of the latest generation of our traditional Faro Arm product, the introduction of the Faro Gage in September 2003, the introduction of our Faro Scan Arm and Digital Template products in 2004, the addition in 2005 of our Faro Laser Scanner LS product, and an increase in the number of sales people worldwide. Our worldwide sales and marketing headcount grew by 103 or 63.2% from 163 at October 2, 2004 to 266 at October 1, 2005. The Digital Template and Faro Laser Scanner products are very recent additions to our product line and did not represent a significant part of our third quarter 2005 growth.

The Company reports both sales and new orders in its quarterly earnings releases. In the third quarter of 2005, new order bookings were approximately $29.5 million, an increase of $6.5 million, or 28.3% compared with approximately $23.0 million in the year-ago quarter. New orders increased 20.4% in the Americas to $13.0 million, from $10.8 million in the third quarter of 2004. New orders increased 15.1% to $10.7 million in Europe/Africa from $9.3 million in the third quarter of 2004. In Asia/Pacific new orders grew 100% to $5.8 million from $2.9 million in the third quarter of 2004.

On November 25, 2003, Cimcore-Romer filed a patent infringement suit against FARO in the Federal District Court for the Southern District of California alleging that certain of the Company’s products sold in the United States, including the FARO Arm, infringe U.S. Patent 5,829,148 ('148 patent). On July 12, 2005, the court issued an order granting Cimcore-Romer's motion for summary judgment of infringement of three claims of the ‘148 patent. In that lawsuit, the Company claimed that it does not infringe the '148 patent and that the '148 patent is invalid. The District Court has not yet ruled on FARO’s allegation that the '148 patent is invalid.

On July 22, 2005, the Company announced its decision to limit the capability of its U.S.-based FARO Arm products (the FARO Arm, the FARO Gage and the Digital Template) by removing what we call the "infinite rotation feature" by reducing this capability to 50 rotations or fewer. FARO believes that by limiting the range of the joint rotation to 50 rotations, it has removed from its U.S. products the ability to sweep through an unlimited arc, which is a feature of the ‘148 patent claims addressed by the court’s ruling required to infringe the '148 patent. The revised products have not, however, been considered by the courts. Accordingly, the Company cannot provide assurance that the revised products will not be deemed to infringe the ‘148 patent.

On September 20, 2005, the Judge presiding over the case withdrew his order of summary infringement and agreed to reconsider his conclusions from the Markman, which is a pretrial hearing often used in patent infringement cases. The new Markman hearing occurred on October 3, 2005 and the hearing-on-summary judgments of infringement is scheduled for November 14, 2005. In addition, the U.S. Patent and Trademark Office has determined that a substantial new question of patentability exists and has granted our request that the '148 patent be reexamined. After investigating and analyzing the Cimcore-Romer infringement claims, we believe that they are without merit, and we plan to continue to defend against them vigorously. In the event of an adverse ruling in the Cimcore-Romer litigation, however, we could be required to pay substantial damages, cease the manufacturing, use and sale of any infringing products, discontinue the use of certain processes or obtain a license, if available, from Cimcore-Romer with royalty payment obligations by us. An adverse decision in the Cimcore-Romer case could materially and adversely affect our financial condition and results of operations. At this time, however, the Company cannot estimate the potential impact, if any, that might result from this suit, and therefore, no provision has been made to cover such expense. The Company has spent approximately $0.8 million in legal fees in the first nine months of 2005 in connection with this case.

Results of Operations

Three Months Ended October 1, 2005 Compared to the Three Months Ended October 2, 2004

Sales increased by $9.2 million or 39.3% from $23.4 million for the three months ended October 2, 2004 to $32.6 million for the three months ended October 1, 2005. This increase resulted primarily from higher product sales due to the effect of an increase in the number of sales people worldwide. Sales in the Americas region increased $3.5 million or 35.0% to $13.5 million for the three months ended October 1, 2005 from $10.0 million in the three months ended October 2, 2004. Sales in the Europe/Africa region increased $0.6 million or 6.1%, to $10.5 million for the three months ended October 1, 2005 from $9.9 million in the three months ended October 2, 2004. Sales in the Asia/Pacific region increased $5.1 million or 146% to $8.6 million for the three months ended October 1, 2005 from $3.5 million in the three months ended October 2, 2004.

Gross profit increased by $2.9 million or 19.6% from $14.8 million for the three months ended October 2, 2004 to $17.7 million for the three months ended October 1, 2005. Gross margin percentage decreased to 54.3% for the three months ended October 1, 2005 from 63.2% for the three months ended October 2, 2004. Gross margin decreased primarily because of an adjustment to cost of goods of approximately $1.6 million related to inventory costing and consumption variances arising from the Company’s implementation of a new enterprise resource planning (“ERP”) system. (See Item 4. Controls and Procedures below)

Selling expenses increased by $2.8 million or 48.3% from $5.8 million for three months ended October 2, 2004 to $8.6 million for the three months ended October 1, 2005. This increase was primarily due to higher compensation and commission expense of $2.2 million, higher marketing costs of $0.5 million and higher product demonstration costs of $0.1 million. As part of our ongoing global sales force expansion, worldwide sales and marketing headcount increased by 103 or 63.2%, from 163 to 266 between October 2, 2004 and October 1, 2005. Regionally, our sales and marketing headcount increased by 24 or 44.4% in the Americas, from 54 to 78, by 35 or 46.1% in Europe/Africa, from 76 to 111, and by 44 or 133% in Asia/Pacific, from 33 to 77 between October 2, 2004 and October 1, 2005. Our sales growth is driven to a large extent by the growth in the number of sales people we have, and there is a natural lag between our hiring and their becoming fully productive. As a percentage of sales, selling expenses increased to 26.4% of sales in the three months ended October 1, 2005 from 24.8% in the three months ended October 2, 2004. Regionally, selling expenses were 25.1% in the Americas for the quarter, compared to 23.0% in the year-ago quarter, 30.4% for Europe/Africa compared to 26.0%, and 23.5% compared to 27.9% for Asia/Pacific.

General and administrative expenses were unchanged at $3.2 million for the three months ended October 2, 2004 and October 1, 2005. General and administrative expenses as a percentage of sales decreased to 9.8% for the three months ended October 1, 2005 from 13.7% for the three months ended October 2, 2004 due to increased sales volume in the current quarter. Regionally, general and administrative expenses were 15.0% in the Americas for the quarter, compared to 18.0% in the year-ago quarter, 6.5% for Europe/Africa compared to 11.2%, and 4.7% compared to 5.6% for Asia/Pacific, respectively.

Depreciation and amortization expenses increased by $0.4 million from $0.6 million for the three months ended October 2, 2004 to $1.0 million for the three months ended October 1, 2005 as a result of increases in depreciation of new equipment and amortization of newly acquired intangibles.

Research and development expenses increased by $0.6 million or 46.2% from $1.3 million for the three months ended October 2, 2004 to $1.9 million for the three months ended October 1, 2005. This increase resulted primarily from an increase in salaries and payments to subcontractors of $0.3 million. Research and development expenses as a percentage of sales increased to 5.8% for the three months ended October 1, 2005 from 5.6% for the three months ended October 2, 2004.

Interest income, net increased by $30,000 from $86,000 for the three months ended October 2, 2004, to $116,000 for the three months ended October 1, 2005 due to an increase in interest rates, partially offset by a reduction in total cash and short-term investments.

Other (expense) income, net increased by $27,000 to an expense of $191,000 for the three months ended October 1, 2005 from expense of $164,000 for the three months ended October 2, 2004.

Income tax expense decreased by $0.3 million from $0.7 million for the three months ended October 2, 2004 to $0.4 million for the three months ended October 1, 2005. This decrease is primarily due to a decrease in taxable income. Total deferred income taxes for the Company’s foreign subsidiaries relating to net operating loss carryforwards were $3.9 million and $3.4 million at October 1, 2005 and December 31, 2004, respectively. The related valuation allowance was $2.1 million and $1.6 million at October 1, 2005 and December 31, 2004, respectively.

Net income decreased by $0.5 million from $3.1 million for the three months ended October 2, 2004 to $2.6 million for the three months ended October 1, 2005 as a result of the factors described above.

Nine Months Ended October 1, 2005 Compared to the Nine Months Ended October 2, 2004

Sales increased by $22.6 million or 33.0% from $68.5 million for the nine months ended October 2, 2004 to $91.1 million for the nine months ended October 1, 2005. This increase resulted primarily from higher product sales due to the effect of an increase in the number of sales people worldwide. Sales in the Americas region increased $10.6 million or 36.8% to $39.4 million for the nine months ended October 1, 2005 from $28.8 million in the nine months ended October 2, 2004. Sales in the Europe/Africa region increased $3.6 million or 11.7%, to $34.4 million for the nine months ended October 1, 2005 from $30.8 million in the nine months ended October 2, 2004. Sales in the Asia/Pacific region increased $8.4 million or 94.4% to $17.3 million for the nine months ended October 1, 2005 from $8.9 million in the nine months ended October 2, 2004.

Gross profit increased by $9.9 million or 22.8% from $43.5 million for the nine months ended October 2, 2004 to $53.4 million for the nine months ended October 1, 2005. Gross margin percentage decreased to 58.6% for the nine months ended October 1, 2005 from 63.5% for the nine months ended October 2, 2004. Gross margin decreased primarily because of higher price discounts, the acquisition of iQvolution, and an adjustment to cost of goods of approximately $1.6 million related to inventory costing and consumption variances arising from the Company’s implementation of a new enterprise resource planning (“ERP”) system. (See Item 4. Controls and Procedures below)

Selling expenses increased by $8.1 million or 46.0% from $17.6 million for the nine months ended October 2, 2004 to $25.7 million for the nine months ended October 1, 2005. This increase was primarily due to higher compensation and commission expense of $6.0 million, higher marketing costs of $1.0 million and higher product demonstration costs of $1.1 million. As part of our ongoing global sales force expansion, worldwide sales and marketing headcount increased by 103 or 63.2%, from 163 to 266 between October 2, 2004 and October 1, 2005. Regionally, our sales and marketing headcount increased by 24 or 44.4% in the Americas, from 54 to 78, by 35 or 46.1% in Europe/Africa, from 76 to 111, and by 44 or 133% in Asia/Pacific, from 33 to 77 between October 2, 2004 and October 1, 2005. Our sales growth is driven to a large extent by the growth in the number of sales people we have, and there is a natural lag between our hiring and their becoming fully productive. As a percentage of sales, selling expenses increased to 28.2% of sales in the nine months ended October 1, 2005 from 25.7% in the nine months ended October 2, 2004. Regionally, selling expenses were 26.3% in the Americas for the nine months ended October 1, 2005, compared to 25.0% in the year-ago period, 29.8% for Europe/Africa compared to 25.6%, and 29.1% compared to 29.5% for Asia/Pacific, respectively. The company had backlog of $0.4 million, $0.7 million and $1.9 million in the Americas, Europe/Africa and Asia/Pacific, respectively at the end of the quarter.

General and administrative expenses increased by $2.6 million or 31.0% from $8.4 million for the nine months ended October 2, 2004 to $11.0 million for the nine months ended October 1, 2005. This increase resulted primarily from higher salaries and bonuses of $1.5 million and higher professional and legal fees of $1.4 million. General and administrative expenses as a percentage of sales decreased to 12.1% for the nine months ended October 1, 2005 from 12.3% for the nine months ended October 2, 2004. Regionally, general and administrative expenses were 18.2% in the Americas for the nine months ended October 1, 2005, compared to 17.6% in the year-ago period, 8.2% for Europe/Africa compared to 7.8%, and 4.7% compared to 7.5% for Asia/Pacific.

Depreciation and amortization expenses increased by $0.7 million from $1.7 million for the nine months ended October 2, 2004 to $2.4 million for the nine months ended October 1, 2005 as a result of increases in depreciation of new equipment and amortization of newly acquired intangibles.

Research and development expenses increased by $0.8 million or 20.0% from $4.0 million for the nine months ended October 2, 2004 to $4.8 million for the nine months ended October 1, 2005. Research and development expenses as a percentage of sales decreased to 5.3% for the nine months ended October 1, 2005 from 5.8% for the nine months ended October 2, 2004.

Interest income, net increased by $185,000 from $234,000 for the nine months ended October 2, 2004, to $419,000 for the nine months ended October 1, 2005 due to an increase in interest rates, partially offset by a reduction in total cash and short-term investments.

Other (expense) income, net decreased by $545,000 to an expense of $330,000 for the nine months ended October 1, 2005 from income of $215,000 for the nine months ended October 2, 2004. This decrease was primarily due to foreign exchange losses.

Income tax expense decreased by $0.7 million from $2.2 million for the nine months ended October 2, 2004 to $1.5 million for the nine months ended October 1, 2005. This decrease is primarily due to a decrease in taxable income. For the nine months ended October 1, 2005, approximately $0.8 million was added to deferred income taxes as a result of the generation of net operating loss carryforwards in certain tax jurisdictions. Of this amount, the Company has recorded a valuation allowance of $0.8 million, as it is more likely than not that these amounts will not be realized based on current estimates of future income in those jurisdictions. For the nine months ended October 1, 2005, the Company utilized $0.4 million of net operating loss carryforwards as a result of income in certain jurisdictions, for which a valuation allowance had been previously applied. Total deferred income taxes for the Company’s foreign subsidiaries relating to net operating loss carryforwards were $3.9 million and $3.4 million at October 1, 2005 and December 31, 2004, respectively. The related valuation allowance was $2.1 million and $1.6 million at October 1, 2005 and December 31, 2004, respectively.

Net income decreased by $2.0 million from $10.0 million for the nine months ended October 2, 2004 to $8.0 million for the nine months ended October 1, 2005 as a result of the factors described above.

Liquidity and Capital Resources

Since 1997, the Company had financed its operations primarily from cash provided by operating activities and from the proceeds of its 1997 initial public offering of common stock (approximately $31.7 million). On November 12, 2003 the Company completed a private placement of its common stock with various institutional investors, resulting in total proceeds before placement agent fees and other offering expenses of $24.9 million.

On September 17, 2003, the Company entered into a loan agreement with SunTrust Bank for a line of credit of $5 million. This agreement was renewed and is due upon demand. The facility bears an interest rate at LIBOR plus 1.75%. The Company has not drawn on this line of credit.

On January 10, 2005, the Company filed a Registration Statement on Form S-3 with the Securities and Exchange Commission allowing it to raise proceeds of up to $125 million. The proceeds from any offerings with respect to this registration statement, if any, would be used for either repayment or refinancing of debt, acquisition of additional businesses or technologies or for working capital and general corporate purposes. To date, we have not raised any capital under this Form S-3 Registration Statement.

Cash and cash equivalents at October 1, 2005 were $11.0 million, compared to $16.4 million at December 31, 2004. The decrease of $5.4 million was primarily attributable to net income of $8.0 million, non-cash charges of $1.6 million, proceeds from sales of investments of $11.5 million and proceeds of $0.3 million from employee stock plan activity. This was offset by changes in operating assets and liabilities of $17.1 million, cash used for the purchase of iQvolution of $6.4 million, cash used for the purchase of property and equipment and payments for intangible assets of $3.1 million and the effect of exchange rate changes on cash of $0.3 million.

We believe that our working capital, together with anticipated cash flow from our operations, our credit facility, and previously announced shelf registration will be sufficient to fund our long-term liquidity requirements.

Critical Accounting Policies

In response to the SEC’s financial reporting release, FR-60, “Cautionary Advice Regarding Disclosure About Critical Accounting Policies,” we have selected our critical accounting policies for purposes of explaining the methodology used in the calculation in addition to any inherent uncertainties pertaining to the possible effects on our financial condition. The critical policies discussed below are our processes of recognizing the reserve for obsolete and slow-moving inventory, income taxes, and the reserve for warranties. These policies affect current assets and operating results and are therefore critical in assessing our financial and operating status. These policies involve certain assumptions that, if incorrect, could create an adverse impact on our operations and financial position.

The Reserve for Obsolescence - Since the value of inventory that will ultimately be realized cannot be known with exact certainty, we rely upon both past sales experience and future sales forecasts. Inventory is considered obsolete if we have withdrawn those products from the market or if we had no sales of the product for the past 12 months, and have no sales forecasted for the next 12 months. Accordingly, a reserve in an amount equal to 100% of the cost of such inventory is recorded in order to reduce the carrying value to net realizable value. While such write-offs have historically been within expectations, we cannot guarantee this will continue in the future.

Income Taxes - We review our deferred income taxes on a regular basis to evaluate their recoverability based on projections of future taxable income in each jurisiction and tax planning strategies that we might employ to utilize such assets, including net operating loss carryforwards. Based on the positive and negative evidence described in Financial Accounting Standards Board Statement No. 109, “Accounting for Income Taxes,” we establish a valuation allowance against the net deferred assets of a taxing jurisdiction in which we operate unless it is “more likely than not” that we will recover such assets through the above means. In the future, our evaluation of the need for the valuation allowance will be significantly influenced by our ability to achieve profitability and our ability to predict and achieve future projections of taxable income.

The Company operates in a number of different countries around the world. In 2003 the Company began to manufacture its products in Switzerland, where it has received a permanent income tax rate commitment from the Swiss government as an incentive to establish a manufacturing plant there. The Company does not provide deferred tax assets on temporary differences scheduled to reverse after the commitment period because all of its earnings are included in the current tax provision.

Significant judgment is required to determine our worldwide provision for income taxes. In the ordinary course of global business, there are many transactions for which the ultimate tax outcome is uncertain. We have appropriately reserved for our tax uncertainties based on the criteria established by SFAS No. 5, “Accounting for Loss Contingencies”.

The Reserve For Warranties - The Company establishes a liability for twelve-month warranties included with the initial purchase price of the equipment by the creation of a warranty reserve, which is an estimate of the repair expenses likely to be incurred for the remaining period of warranty measured in installation-months in each major product group. Warranty reserve is reflected in accrued liabilities in the accompanying consolidated balance sheets. The warranty expense is estimated by determining the total repair expenses for each product group in the period and determining a rate of repair expense per installation month. The rate is multiplied by the number of machine-months of warranty for each product group sold during the period to determine the provision for warranty expenses for the period. The Company reevaluates its exposure to warranty costs at the end of each period using the estimated expense per installation month for each major product group, the number of machines remaining under warranty and the remaining number of months each machine will be under warranty. While such expenses have historically been within expectations, we cannot guarantee this will continue in the future.

Transactions with Related and Other Parties

The Company leases its headquarters in Lake Mary, Florida from Xenon Research, Inc., all of the issued and outstanding capital stock of which is owned by Simon Raab, the Company's Chief Executive Officer, and Diana Raab, his spouse. The term of the lease expires on February 28, 2006, and the Company has a five-year renewal option. Base rent during renewal periods will reflect changes in the U.S. Bureau of Labor Statistics Consumer Price Index for all Urban Consumers. Management is currently assessing its needs in regards to the potential renewal of this agreement.

Foreign Exchange Exposure

We conduct a significant portion of our business outside the United States. At present, approximately 55% of our revenues are invoiced, and a significant portion of our operating expenses paid, in foreign currencies. Fluctuations in exchange rates between the U.S. dollar and such foreign currencies may have a material adverse effect on our business, results of operations and financial condition, and could specifically result in foreign exchange gains and losses. The impact of future exchange rate fluctuations on the results of our operations cannot be accurately predicted. To the extent that the percentage of our non-U.S. dollar revenues derived from international sales increases (or decreases) in the future, our exposure to risks associated with fluctuations in foreign exchange rates may increase (or decrease).

Item 3. Quantitative and Qualitative Disclosures about Market Risk

The information required by this item is incorporated by reference herein from the section of this Report in Part I, Item 2, under the caption “Foreign Exchange Exposure”, above.

Item 4. Controls and Procedures

As of the end of the period covered by this Quarterly Report on Form 10-Q, management carried out an evaluation, under the supervision and with the participation of its Chief Executive Officer and its principal financial officer, of the effectiveness of the design and operation of its disclosure controls and procedures as such term is defined under Securities Exchange Act of 1934, as amended (the “Exchange Act”) Rule 13a-15(e). Based on this evaluation, management has concluded that such disclosure controls and procedures were, as a result of the inventory-related reason stated in the following paragraph, ineffective to provide reasonable assurance that the Company records, processes, summarizes and reports the information the Company must disclose in reports that the Company files or submits under the Exchange Act within the time periods specified in the SEC’s rules and forms.

The changes in the company’s internal control over financial reporting described in the previous paragraph were implemented prior to the Company reporting its results for the quarter and nine months ended October 1, 2005. There were no other changes in the Company’s internal control over financial reporting during the quarter ended October 1, 2005 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceedings

On November 25, 2003, Cimcore-Romer filed a patent infringement suit against us in the Federal District Court for the Southern District of California alleging that certain of our products sold in the United States, including the FARO Arm, infringe U.S. Patent 5,829,148 ('148 patent). On July 12, 2005, the court issued an order granting Cimcore-Romer's motion for summary judgment of infringement of three claims of the ‘148 patent. In that lawsuit, we claimed that we do not infringe the '148 patent and that the '148 patent is invalid. The District Court has not yet ruled on our allegation that the '148 patent is invalid.

On July 22, 2005, the Company announced its decision to limit the capability of its U.S.-based FARO Arm products (the FARO Arm, the FARO Gage and the Digital Template) by removing what we call the "infinite rotation feature" by reducing this capability to 50 rotations or fewer. FARO believes that by limiting the range of the joint rotation to 50 rotations, it has removed from its U.S. products the ability to sweep through an unlimited arc, which is a feature of the ‘148 patent claims addressed by the court’s ruling required to infringe the '148 patent. The revised products have not, however, been considered by the courts. Accordingly, we cannot assure you that the revised products will not be deemed to infringe the ‘148 patent.

On September 20, 2005, the Judge presiding over the case withdrew his order of summary judgment of infringement and agreed to reconsider his conclusions from the Markman, which is a pretrial hearing often used in patent infringement cases. The new Markman hearing occurred on October 3, 2005 and the hearing-on-summary judgments of infringement is scheduled for November 14, 2005. In addition, the U.S. Patent and Trademark Office has determined that a substantial new question of patentability exists and has granted our request that the '148 patent be reexamined. After investigating and analyzing the Cimcore-Romer infringement claims, we believe that they are without merit, and we plan to continue to defend against them vigorously. In the event of an adverse ruling in the Cimcore-Romer litigation, however, we could be required to pay substantial damages, cease the manufacturing, use and sale of any infringing products, discontinue the use of certain processes or obtain a license, if available, from Cimcore-Romer with royalty payment obligations by us. An adverse decision in the Cimcore-Romer case could materially and adversely affect our financial condition and results of operations. At this time, however, the Company cannot estimate the potential impact, if any, that might result from this suit, and therefore, no provision has been made to cover such expense.

Item 4. Submission of Matters to a Vote of Security Holders

None.

Item 5. Other Information

None.

Item 6. Exhibits

31-A

Certification of the Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31-B

Certification of the Principal Financial and Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32-A

Certification of the Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32-B

Certification of the Principal Financial and Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	FARO Technologies, Inc.
	(Registrant)

Date: November 8, 2005	By:	/s/ Barbara R. Smith
		Barbara R. Smith
		Senior Vice President and Chief Financial Officer
		(Duly Authorized Officer and Principal Financial Officer)

Unassociated Document

EXHIBIT 31-A

FARO Technologies, Inc.

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Simon Raab, Chairman of the Board and Chief Executive Officer of FARO Technologies, Inc., certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of FARO Technologies, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-(15)(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-(15)(f) and 15(d)-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.


Date: November 8, 2005


/s/ Simon Raab
Name: Simon Raab
Title: Chief Executive Officer-Director (Principal Executive Officer)

Unassociated Document

EXHIBIT 31-B

FARO Technologies, Inc.

Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Barbara R. Smith, Senior Vice President and Chief Financial Officer of FARO Technologies, Inc. and the principal financial officer and principal accounting officer of FARO Technologies, Inc. for the period covered by this Quarterly Report on Form 10-Q, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of FARO Technologies, Inc.;

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.


Date: November 8, 2005


/s/ Barbara R. Smith
Name: Barbara R. Smith
Title: Senior Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)

Unassociated Document

EXHIBIT 32-A

FARO Technologies, Inc.

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Solely for the purposes of complying with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, the undersigned Chairman of the Board, President, Chief Executive Officer and Director of FARO Technologies, Inc., (the Company) hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q, for the quarter ended October 1, 2005 (the Report) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Simon Raab
Simon Raab
November 8, 2005

Unassociated Document

EXHIBIT 32-B

FARO Technologies, Inc.

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Solely for the purposes of complying with 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, the undersigned Senior Vice President, Chief Financial Officer, and Director of FARO Technologies, Inc., (the Company), and the principal financial officer and principal accounting officer of the Company for the period covered the Report, hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q, for the quarter ended October 1, 2005 (the Report) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


/s/ Barbara R. Smith
Barbara R. Smith
November 8, 2005